EA201300540A1 - Способ лечения, облегчения и/или предупреждения колоректального рака - Google Patents

Способ лечения, облегчения и/или предупреждения колоректального рака

Info

Publication number
EA201300540A1
EA201300540A1 EA201300540A EA201300540A EA201300540A1 EA 201300540 A1 EA201300540 A1 EA 201300540A1 EA 201300540 A EA201300540 A EA 201300540A EA 201300540 A EA201300540 A EA 201300540A EA 201300540 A1 EA201300540 A1 EA 201300540A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
colorectal cancer
relief
peg
Prior art date
Application number
EA201300540A
Other languages
English (en)
Inventor
Коринне Де Врис
Лейтон Джонс
Иэн Кокс
Йорг Плессль
Сэмюель Смит
Питер Стейн
Речел Чарлтон
Original Assignee
Норджин Бв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Норджин Бв filed Critical Норджин Бв
Publication of EA201300540A1 publication Critical patent/EA201300540A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Настоящее изобретение относится к способам лечения, облегчения или предупреждения колоректального рака (КРР) у человека при использовании полиэтиленгликоля (ПЭГ) или блок-сополимеров ПЭГ, таких как Pluronic® F68. Описаны также композиции, предназначенные для лечения, облегчения и/или предупреждения КРР, содержащие ПЭГ. Данные композиции могут быть использованы в способах, соответствующих изобретению.
EA201300540A 2010-11-04 2011-11-04 Способ лечения, облегчения и/или предупреждения колоректального рака EA201300540A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
US41212810P 2010-11-10 2010-11-10
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (1)

Publication Number Publication Date
EA201300540A1 true EA201300540A1 (ru) 2013-09-30

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300540A EA201300540A1 (ru) 2010-11-04 2011-11-04 Способ лечения, облегчения и/или предупреждения колоректального рака

Country Status (22)

Country Link
US (2) US20130216493A1 (ru)
EP (1) EP2635289B1 (ru)
JP (1) JP5917537B2 (ru)
KR (1) KR20130109171A (ru)
CN (1) CN103313719A (ru)
AR (1) AR083770A1 (ru)
AU (1) AU2011324996B2 (ru)
BE (1) BE1019494A3 (ru)
BR (1) BR112013011012A2 (ru)
CA (1) CA2816839A1 (ru)
EA (1) EA201300540A1 (ru)
ES (1) ES2401269B1 (ru)
GB (1) GB201018650D0 (ru)
MX (1) MX349690B (ru)
MY (1) MY163067A (ru)
NL (1) NL2007715C2 (ru)
NZ (1) NZ611145A (ru)
SG (1) SG189533A1 (ru)
TW (1) TWI606832B (ru)
UA (1) UA107998C2 (ru)
WO (1) WO2012059725A1 (ru)
ZA (1) ZA201304052B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
KR20170098980A (ko) 2012-09-11 2017-08-30 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
TW201431556A (zh) * 2012-10-26 2014-08-16 Univ Northshore Healthsystem 用於頭部和頸部鱗狀細胞癌之療法的包含聚乙二醇之組成物
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
EP3934663A1 (en) * 2019-03-05 2022-01-12 Dow Global Technologies LLC Polyethyleneglycol derivatives for inducing caspase activity
CN113507933B (zh) * 2019-03-05 2024-05-10 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Also Published As

Publication number Publication date
CA2816839A1 (en) 2012-05-10
AU2011324996A1 (en) 2013-05-02
US20160228467A1 (en) 2016-08-11
SG189533A1 (en) 2013-05-31
MX349690B (es) 2017-08-09
TWI606832B (zh) 2017-12-01
US20130216493A1 (en) 2013-08-22
AR083770A1 (es) 2013-03-20
ZA201304052B (en) 2014-02-26
JP5917537B2 (ja) 2016-05-18
MX2013004963A (es) 2013-08-27
BE1019494A3 (fr) 2012-07-03
KR20130109171A (ko) 2013-10-07
GB201018650D0 (en) 2010-12-22
NZ611145A (en) 2015-07-31
MY163067A (en) 2017-08-15
ES2401269B1 (es) 2014-02-19
CN103313719A (zh) 2013-09-18
UA107998C2 (uk) 2015-03-10
JP2013544809A (ja) 2013-12-19
WO2012059725A8 (en) 2013-05-30
EP2635289B1 (en) 2020-03-11
WO2012059725A1 (en) 2012-05-10
BR112013011012A2 (pt) 2016-08-23
EP2635289A1 (en) 2013-09-11
NL2007715A (en) 2012-05-07
TW201304785A (zh) 2013-02-01
NL2007715C2 (en) 2012-10-16
ES2401269A1 (es) 2013-04-18
AU2011324996B2 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
MX2021013830A (es) Inhibidores de ezh2 para tratar linfomas.
EA201300540A1 (ru) Способ лечения, облегчения и/или предупреждения колоректального рака
EP4140487A8 (en) Combination therapy for treating cancer
MX2016007351A (es) Terapia de combinacion para tratar cancer.
EA201590987A1 (ru) Соединения и способы их применения
EA201291031A1 (ru) Способ лечения ожирения с применением антиоксидантных модуляторов воспаления
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
MX347225B (es) Metodos de tratamiento contra el cancer pancreatico.
MX2017013142A (es) Terapia combinada para tratar cáncer.
EA201300171A1 (ru) Способы и композиции для терапии рака печени
BR112015007878A2 (pt) composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos
MX363243B (es) Composiciones para tratar cáncer y usos de dichas composiciones.
MX369691B (es) Inhibidores de glutaminasa y métodos de empleo.
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
UA107783C2 (en) Isoindoline compounds for use in treating cancer
WO2014164704A3 (en) Compounds and compositions for the treatment of cancer
MX349886B (es) Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas.
MX2013003282A (es) Materiales y metodos para mejorar la funcion gastrointestinal.
EA201290356A1 (ru) Композиции для лечения тошноты и рвоты центрального происхождения
MX2013001237A (es) Compuestos inhibidores del virus de la hepatitis c.
EA201591925A1 (ru) Терапевтические композиции и их применение
EA201001749A1 (ru) Способ лечения недифференцированного артрита
EA201492187A1 (ru) Способы лечения солидных опухолей с использованием кофермента q10
WO2015067755A3 (en) Novel methods and antibodies for treating coagulapathy
EA201591424A1 (ru) Способы лечения дефицита железа растворимым пирофосфатом железа